PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Molecular Biology and Pathology, National Research Council of Italy (CNR), Rome, Italy.\', \'Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.\', \'National Institute for Cardiovascular Research, Bologna, Italy.\', \'Immunosurveillance Laboratory, The Francis Crick Institute, London, United Kingdom.\', \'Peter Gorer Department of Immunobiology, King\'s College London, London, United Kingdom.\', \'National Institute for Health Research (NIHR) Biomedical Research Center (BRC), Guy\'s and St Thomas\' NHS Foundation Trust and King\'s College London, London, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.653974
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 33897702
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all